Institute

India will likely take at least three to four months to complete Covid-19 inoculation efforts for frontline workers and people above 60, or with underlying health conditions, the executive director …

Vaccine hesitancy in India is dropping significantly, according to a nation-wide survey, which found that the percentage of citizens willing to take the COVID-19 vaccine immediately has increased from 31% …

India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of …

A local court has rejected an application seeking injunction against the use of `Covishield’ as brandname by the vaccine-maker Serum Institute of India (SII), the company said on Saturday. SII …

However, its efficacy dropped to 60% when it was tested in volunteers in South Africa American company Novavax, whose COVID-19 vaccine is set to be made in large numbers by …

If candidates want to challenge the answer key in case of any discrepancies, they can do so on the official website till 30 January Representational image. Wikimedia Commons IIFT 2021: The …

South Africa Health Minister Zweli Mkhize on Friday announced that the South African Health Products Regulatory Authority (SAHPRA) has granted approval to Serum Institute of India (SII) to supply COVID-19 vaccine …

Three Maharashtra government agencies launched a probe into Serum Institute of India fire on Friday. The fire at the world’s largest vaccine manufacturer killed five workers. SII is manufacturing coronavirus …

Meanwhile, Chief Minister Uddhav Thackeray is set to visit the facility to take stock of the situation tomorrow. The Maharashtra govt has also ordered a probe into the cause of …

Hours after a fire was extinguished, new blazes broke out in a compartment of the same building Serum Institute of India in Pune.  Earlier, at least five people died as a major …

Fire at Serum Institute of India LIVE Updates: Five persons were killed in a blaze that broke out today afternoon at SII plant in Pune’s Manjari area. Maharshtra chief minister …

 Smoke billows out after a massive fire broke out at the Serum Institute of India, in Pune, Thursday, Jan. 21, 2021. The facility had rolled out its Covishield vaccine for …

New Delhi: People who are severely allergic to any ingredient of COVID-19 vaccine ‘Covishield’ are advised not to take it, Serum Institute of India said. According to the fact sheet …

Hyderabad-headquartered Bharat Biotech flew the first batch of Covaxin, its two-dose Covid-19 vaccine, to 11 cities across India on Wednesday, a day after Serum Institute of India (SII) shipped batches …

In a major announcement, Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday (January 12) said that ‘Covishield’ will be made available in private markets at Rs 1,000 after …

South Africa will be receiving 1.5 million doses of vaccine from Serum Institute of India (SII), country’s health minister, Dr Zweli Mkhize said in a statement.  “Today, I am pleased …

A civil court in Pune on Tuesday issued a notice to the Serum Institute of India (SII) on a suit filed by a pharmaceutical products manufacturer and seller seeking to …

Serum Institute of India CEO Adar Poonawalla and Bharat Biotech managing director Dr Krishna Ella have in a joint statement Tuesday said that it was their combined intent to develop, …

Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and will be priced at double that rate in …

India’s Central Drugs Standard Control Organisation’s Subject Expert Committee(SEC) is set to hold a meeting today to decide on approving the Covishield vaccine developed by Serum Institute of India (SII) …

New Delhi: Vaccine manufacturing major Serum Institute of India (SII) on Monday said it has applied to Drugs Controller General of India (DCGI) for emergency use authorisation for its COVID-19 …

The Serum Institute of India (SII) on December 6 applied to the Drugs Controller General of India (DCGI) to seek emergency use authorisation for its COVID-19 vaccine candidate Covishield. It is …

Hyderabad-based GSITI saw more than 200% increase in its training programmes over the average figure during pre-pandemic years The COVID-19 pandemic has been a blessing in disguise for the Geological …

After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking Covishield Covid-19 vaccine during the human trials, Serum Institute of India has once again asserted …

The Serum Institute of India has demanded Rs 100 crore as damages to its reputation in a defamation suit after a Chennai-based volunteer served a legal notice to the Serum …